Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort

Documents similaires

• Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study
  par: Yun Wang, et autres
  Publié: (2025)
• Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
  par: Jiaying Ni, et autres
  Publié: (2025)
• Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
  par: Jingchuan Guo, et autres
  Publié: (2024)
• Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States
  par: Reema Mody, et autres
  Publié: (2025)
• Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data
  par: Alex E. Henney, et autres
  Publié: (2024)